Finance

Beta
Lists
DOSE:CNSX
Rapid Dose Therapeutics Corp
CA$0.095
-5.00%
(-0.0050) 1D
Jun 5, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for DOSE...
Open
CA$0.10
High
CA$0.10
Low
CA$0.10
Mkt. cap
12.96M
Avg. vol.
31.15K
Volume
2.00K
52-wk high
CA$0.24
52-wk low
CA$0.08
EPS
-CA$0.04
Open
CA$0.10
High
CA$0.10
Low
CA$0.10
Mkt. cap
12.96M
Avg. vol.
31.15K
Volume
2.00K
52-wk high
CA$0.24
52-wk low
CA$0.08
EPS
-CA$0.04
News stories
From sources across the web
About Rapid Dose Therapeutics Corp
CEO-
Employees-
Founded2008
HeadquartersBurlington, Ontario, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Feb 2025
May 2025
Aug 2025
Nov 2025
Revenue
668.58K
782.74K
672.92K
657.14K
Cost of goods sold
343.55K
391.03K
296.47K
347.34K
Cost of revenue
343.55K
391.03K
296.47K
347.34K
Research and development expenses
48.62K
-14.55K
19.39K
15.20K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.18M
639.60K
691.93K
792.49K
Operating expense
1.67M
895.76K
919.24K
998.15K
Total operating expenses
2.01M
1.29M
1.22M
1.35M
Operating income
-1.34M
-504.05K
-542.79K
-688.35K
Other non operating income
-
-
-
-
EBT including unusual items
-1.68M
-723.68K
-825.47K
-1.14M
EBT excluding unusual items
-1.68M
-723.68K
-825.47K
-1.14M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.68M
-723.68K
-825.47K
-1.14M
Net profit margin
-251.55%
-92.45%
-122.67%
-173.56%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-338.47K
-219.63K
-282.69K
-452.16K
Net interest expenses
-338.47K
-219.63K
-282.69K
-452.16K
Depreciation and amortization charges
59.65K
133.78K
135.20K
126.60K
EBITDA
-1.31M
-461.22K
-501.96K
-656.12K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more